Financial News
Latest News about Briefs
Recent news which mentions Briefs
From Benzinga
From Benzinga
From Benzinga
Burlington Stock Jumps As Q4 Earnings Crush Estimates, But CEO Warns Of 'Uncertain' 2025 Outlook
March 06, 2025
From Benzinga
From Benzinga
ChatGPT Parent OpenAI's Specialized AI Agents Could Cost Up To $20 Thousand Per Month: report
March 06, 2025
From Benzinga
What's Going On With United Microelectronics Stock Today?
March 06, 2025
From Benzinga
From Benzinga
Why Is Nauticus Robotics Stock Soaring Today?
March 06, 2025
From Benzinga
From Benzinga
From Benzinga
Chevron Meeting Takeaways: Goldman Sachs Analyst Highlights Expectations For Volume And FCF Inflection
March 05, 2025
From Benzinga
On Holding's Growth Soars: Analysts See Strong Upside Amid New Initiatives Beyond Footwear, Star-Studded Marketing
March 05, 2025
From Benzinga
Analysts Highlight Credo Hyperscaler Partnerships With Amazon, Microsoft, xAI Amid AI Boom
March 05, 2025
From Benzinga
From Benzinga
From Benzinga
Beyond's Road To Profitability Gets Bumpier: Analyst Warns Of Volatility As EBITDA Milestone Delayed
March 05, 2025
From Benzinga
FDA Places Clinical Hold On BioNTech's Early-Phase Trial For RNA-Based Malaria Vaccine
March 05, 2025
From Benzinga
AutoZone's Growth Story Intact, Analysts Highlight Commercial Strength and Expansion Plans
March 05, 2025
From Benzinga
Bristol Myers Acquired MyoKardia Drops Fulcrum Agreement, Ending Cardiomyopathy Research Deal
March 05, 2025
From Benzinga
From Benzinga
Ross Stores Faces Slower Growth With Shifts In Lower-Income Customers Preference, Says Analyst
March 05, 2025
From Benzinga
Box Sees Strong Q4 Bookings And AI Expansion, But Margin Outlook Prompts Analyst Adjustments
March 05, 2025
From Benzinga
Taiwan Semiconductor Caught Between US Tariff Threats and Taiwan's Push To Keep Advanced Chip Tech
March 05, 2025
From Benzinga
From Benzinga
Royal Caribbean To Benefit From Industry Tailwinds Along With Unique Structural Factors, Says Analyst
March 05, 2025
From Benzinga
Silexion Therapeutics' Preclinical Cancer Candidate Shows Tumor Reduction For Pancreatic Cancer
March 05, 2025
From Benzinga
From Benzinga
Bayer CEO: 2025 Will Be 'Most Difficult' Year In Turnaround Plan, Expects Improved Performance From 2026 Onwards
March 05, 2025
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
